Initially investigated for its potential to treat neurodegenerative diseases like Alzheimers and Parkinsons, this small synthetic peptide is known to bind with high affinity to hepatocyte growth factor (HGF) and its receptor c-Met, thereby promoting neuronal differentiation, dendritic branching, and synaptic plasticity
Through interactions with PGC-1 coactivators and chromatin regulators, ERRs govern programs for mitochondrial biogenesis, oxidative phosphorylation (OXPHOS), lipid catabolism, and angiogenesis
These findings provide a solid mechanistic foundation for the future development of BPC157-based or sequential therapeutic agents targeted at enhancing vascular repair
Peptide enhancement: Direct chondrocyte stimulation evidence limited for most peptides
I-vit 12 Injection is supplied as a injection and is taken by the parenteral route
We offer personalized peptide therapy services that are tailored to your fitness goals